Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jul;63(7):2391–2395. doi: 10.1128/iai.63.7.2391-2395.1995

Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.

A G Harmsen 1, W Chen 1, F Gigliotti 1
PMCID: PMC173319  PMID: 7790048

Abstract

Immunocompetent C.B-17 mice were immunized against Pneumocystis carinii by several intratracheal inoculations with infective P. carinii. These mice and another group of C.B-17 mice naive to P. carinii were then depleted of CD4+ cells by treatment with both anti-CD4 and anti-Thy1 monoclonal antibodies. Both groups of mice were then challenged with an infective inoculum containing 10(7) P. carinii organisms by intratracheal instillation. The mean log10 counts of P. carinii nuclei in the lungs of the nonimmune mice were 4.98, 5.89, and 6.77 when they were killed at 4, 10, and 19 days, respectively, after challenge. The P. carinii counts in the lungs of the immune mice were significantly lower at each time point and below detectable levels at 10 and 19 days. Analysis of P. carinii DNA by PCR revealed no detectable P. carinii in the lungs of the immunized mice at either 10 or 19 days, whereas all of the nonimmunized mice contained P. carinii DNA at all time points. The sera of immune but not nonimmune mice contained P. carinii-specific immunoglobulin G. These results indicate that immunization of an immunocompetent host against P. carinii can protect against P. carinii pneumonia even after the host is depleted of CD4+ cells. In addition, the results are consistent with the possibility that antibodies were responsible for the observed protection against P. carinii.

Full Text

The Full Text of this article is available as a PDF (296.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bottomly K., Luqman M., Greenbaum L., Carding S., West J., Pasqualini T., Murphy D. B. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol. 1989 Apr;19(4):617–623. doi: 10.1002/eji.1830190407. [DOI] [PubMed] [Google Scholar]
  2. Budd R. C., Cerottini J. C., Horvath C., Bron C., Pedrazzini T., Howe R. C., MacDonald H. R. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol. 1987 May 15;138(10):3120–3129. [PubMed] [Google Scholar]
  3. Chace J. H., Cowdery J. S., Field E. H. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J Immunol. 1994 Jan 15;152(2):405–412. [PubMed] [Google Scholar]
  4. Chen W., Gigliotti F., Harmsen A. G. Latency is not an inevitable outcome of infection with Pneumocystis carinii. Infect Immun. 1993 Dec;61(12):5406–5409. doi: 10.1128/iai.61.12.5406-5409.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen W., Harp J. A., Harmsen A. G. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun. 1993 Sep;61(9):3928–3932. doi: 10.1128/iai.61.9.3928-3932.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen W., Havell E. A., Gigliotti F., Harmsen A. G. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun. 1993 Jan;61(1):97–102. doi: 10.1128/iai.61.1.97-102.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cushion M. T., Ruffolo J. J., Walzer P. D. Analysis of the developmental stages of Pneumocystis carinii, in vitro. Lab Invest. 1988 Mar;58(3):324–331. [PubMed] [Google Scholar]
  8. Feldman S., Gigliotti F., Shenep J. L., Roberson P. K., Lott L. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis. 1990 May;161(5):926–931. doi: 10.1093/infdis/161.5.926. [DOI] [PubMed] [Google Scholar]
  9. Gershon A. A., Steinberg S. P. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med. 1989 Apr 6;320(14):892–897. doi: 10.1056/NEJM198904063201403. [DOI] [PubMed] [Google Scholar]
  10. Gigliotti F., Harmsen A. G., Haidaris C. G., Haidaris P. J. Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun. 1993 Jul;61(7):2886–2890. doi: 10.1128/iai.61.7.2886-2890.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gigliotti F. Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J Infect Dis. 1992 Feb;165(2):329–336. doi: 10.1093/infdis/165.2.329. [DOI] [PubMed] [Google Scholar]
  12. Gigliotti F., Hughes W. T. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest. 1988 Jun;81(6):1666–1668. doi: 10.1172/JCI113503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harmsen A. G., Chen W. Resolution of Pneumocystis carinii pneumonia in CD4+ lymphocyte-depleted mice given aerosols of heat-treated Escherichia coli. J Exp Med. 1992 Sep 1;176(3):881–886. doi: 10.1084/jem.176.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harmsen A. G. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect Immun. 1988 Aug;56(8):1858–1863. doi: 10.1128/iai.56.8.1858-1863.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harmsen A. G., Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med. 1990 Sep 1;172(3):937–945. doi: 10.1084/jem.172.3.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hughes W. T., Kim H. K., Price R. A., Miller C. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr Ther Res Clin Exp. 1973 Aug;15(8):581–587. [PubMed] [Google Scholar]
  17. Janoff E. N., Douglas J. M., Jr, Gabriel M., Blaser M. J., Davidson A. J., Cohn D. L., Judson F. N. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis. 1988 Nov;158(5):983–990. doi: 10.1093/infdis/158.5.983. [DOI] [PubMed] [Google Scholar]
  18. Kaneshiro E. S., Wu Y. P., Cushion M. T. Assays for testing Pneumocystis carinii viability. J Protozool. 1991 Nov-Dec;38(6):85S–87S. [PubMed] [Google Scholar]
  19. Lundgren B., Lundgren J. D., Nielsen T., Mathiesen L., Nielsen J. O., Kovacs J. A. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia. J Infect Dis. 1992 Jun;165(6):1151–1155. doi: 10.1093/infdis/165.6.1151. [DOI] [PubMed] [Google Scholar]
  20. Peglow S. L., Smulian A. G., Linke M. J., Pogue C. L., Nurre S., Crisler J., Phair J., Gold J. W., Armstrong D., Walzer P. D. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis. 1990 Feb;161(2):296–306. doi: 10.1093/infdis/161.2.296. [DOI] [PubMed] [Google Scholar]
  21. Pifer L. L., Hughes W. T., Stagno S., Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics. 1978 Jan;61(1):35–41. [PubMed] [Google Scholar]
  22. Roths J. B., Sidman C. L. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J Clin Invest. 1992 Aug;90(2):673–678. doi: 10.1172/JCI115910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Roths J. B., Sidman C. L. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect Immun. 1993 May;61(5):1641–1649. doi: 10.1128/iai.61.5.1641-1649.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shellito J., Suzara V. V., Blumenfeld W., Beck J. M., Steger H. J., Ermak T. H. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest. 1990 May;85(5):1686–1693. doi: 10.1172/JCI114621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Steinhoff M. C., Auerbach B. S., Nelson K. E., Vlahov D., Becker R. L., Graham N. M., Schwartz D. H., Lucas A. H., Chaisson R. E. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med. 1991 Dec 26;325(26):1837–1842. doi: 10.1056/NEJM199112263252603. [DOI] [PubMed] [Google Scholar]
  26. Wright T. W., Simpson-Haidaris P. J., Gigliotti F., Harmsen A. G., Haidaris C. G. Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species. Infect Immun. 1994 May;62(5):1513–1519. doi: 10.1128/iai.62.5.1513-1519.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES